These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 5417217)

  • 21. [Wilson's disease (hepatolenticular degeneration)].
    Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
    Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
    [No Abstract]   [Full Text] [Related]  

  • 22. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
    Gregersen G; Frederiksen G
    Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
    Hayek HW; Schnack H; Widhalm S
    Wien Klin Wochenschr; 1973 Feb; 85(8):122-5. PubMed ID: 4632215
    [No Abstract]   [Full Text] [Related]  

  • 24. Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.
    Chan CY; Baker AL
    Am J Gastroenterol; 1994 Mar; 89(3):442-3. PubMed ID: 8122662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the therapeutic combination of S-adenosylmethionine with D-penicillamine in Wilson's disease].
    Gasbarrini G; Miglio F; Corazza GR; Stefanini GF
    Minerva Med; 1975 May; 66(33):1600-4. PubMed ID: 1143693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pemphigus in a patient treated with penicillamine for Wilson's disease].
    Degos R; Touraine R; Belaïch S; Revuz J
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):751-3. PubMed ID: 5384189
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatolenticular degeneration (Wilson's disease).
    Wis Med J; 1970 Mar; 69(3):105-10. PubMed ID: 5434427
    [No Abstract]   [Full Text] [Related]  

  • 28. Wilson's disease: varied manifestations and consequences of non-compliance with treatment.
    Breen E; Tolan M; Meaney J; Lucey C; McCarthy C; O'Gorman T
    Ir Med J; 1987 Dec; 80(12):424-5. PubMed ID: 3436787
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatic changes in the neurological form of Wilson's disease].
    Hauftová D; Hartl J; Slavícek J; Valach V; Fialová J; Pojerová M
    Vnitr Lek; 1967 Nov; 13(11):1064-9. PubMed ID: 6081668
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic effects of penicillamine on Wilson's disease].
    Takagi H; Yoshida K; Okamura S; Maehashi M
    Nihon Rinsho; 1965 Oct; 23(10):2038-44. PubMed ID: 5895380
    [No Abstract]   [Full Text] [Related]  

  • 31. [Wilson's disease (experience of long-term treatment with penicillamine---con penicilamina].
    Escartín Marín P; García Plaza A; Chantar Barrios C
    Rev Clin Esp; 1974 Jun; 133(5):451-4. PubMed ID: 4215106
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
    Anlar B; Kuruoğlu R; Varli K; Topçu M
    Muscle Nerve; 1996 May; 19(5):676-7. PubMed ID: 8618573
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy and rehabilitation of Wilson's disease (author's transl)].
    Eichner B; Lössner J; Bachmann H; Diessner H; Biesold D; Günther K
    Folia Clin Int (Barc); 1974 Nov; 24(11):776-92. PubMed ID: 4435281
    [No Abstract]   [Full Text] [Related]  

  • 34. [Contribution to the clarification of the pathogenesis of osteopathies in Wilson's disease. (Hepatolenticular degeneration)].
    Vokrouhlická-RösslerovI ; Vodicková L; Neruda O
    Vnitr Lek; 1967 Oct; 13(10):1018-22. PubMed ID: 5630545
    [No Abstract]   [Full Text] [Related]  

  • 35. The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
    Bell GE; Slivka DC; Huston JR
    J Lab Clin Med; 1968 Jan; 71(1):113-21. PubMed ID: 5634999
    [No Abstract]   [Full Text] [Related]  

  • 36. [Penicillamine treatment of Wilson's disease].
    Falkmer S; Samuelson G; Sjölin S
    Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current problems of Wilson's disease (hepatolenticular degeneration)].
    Julesz J; Bodor F; Szarvas F
    Orv Hetil; 1969 Dec; 110(49):2857-60. PubMed ID: 5364763
    [No Abstract]   [Full Text] [Related]  

  • 38. [2 cases of Wilson's disease with hepatic precession in biliary lithiasis].
    Dupuy R; Vallin J; Fabiani F
    Rev Int Hepatol; 1969; 19(4):233-40. PubMed ID: 5404531
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of Wilson's disease.
    Richardson JC
    Mod Treat; 1968 Mar; 5(2):321-31. PubMed ID: 5655947
    [No Abstract]   [Full Text] [Related]  

  • 40. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.